Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 377

1.

Development of a Method to Implement Whole-Genome Bisulfite Sequencing of cfDNA from Cancer Patients and a Mouse Tumor Model.

Maggi EC, Gravina S, Cheng H, Piperdi B, Yuan Z, Dong X, Libutti SK, Vijg J, Montagna C.

Front Genet. 2018 Jan 23;9:6. doi: 10.3389/fgene.2018.00006. eCollection 2018.

2.

Tocilizumab in Giant Cell Arteritis: A Real-Life Retrospective Study.

Vitiello G, Orsi Battaglini C, Carli G, Radice A, Matucci A, Vultaggio A, Olianti C, Parronchi P, Maggi E, Cammelli D.

Angiology. 2018 Jan 1:3319717753223. doi: 10.1177/0003319717753223. [Epub ahead of print]

PMID:
29343075
3.

Bioerosive and bioprotective role of barnacles on rocky shores.

Pappalardo M, Maggi E, Geppini C, Pannacciulli F.

Sci Total Environ. 2018 Apr 1;619-620:83-92. doi: 10.1016/j.scitotenv.2017.10.281. Epub 2017 Nov 13.

PMID:
29145057
4.

Angiogenic T cell expansion correlates with severity of peripheral vascular damage in systemic sclerosis.

Manetti M, Pratesi S, Romano E, Bellando-Randone S, Rosa I, Guiducci S, Fioretto BS, Ibba-Manneschi L, Maggi E, Matucci-Cerinic M.

PLoS One. 2017 Aug 10;12(8):e0183102. doi: 10.1371/journal.pone.0183102. eCollection 2017.

5.

IL-10-Producing Infliximab-Specific T Cells Regulate the Antidrug T Cell Response in Exposed Patients.

Vultaggio A, Nencini F, Pratesi S, Cammelli D, Totaro M, Romagnani S, Maggi E, Matucci A; ABIRISK Consortium.

J Immunol. 2017 Aug 15;199(4):1283-1289. doi: 10.4049/jimmunol.1700008. Epub 2017 Jul 17.

PMID:
28716826
6.

Musculin inhibits human T-helper 17 cell response to interleukin 2 by controlling STAT5B activity.

Santarlasci V, Mazzoni A, Capone M, Rossi MC, Maggi L, Montaini G, Rossettini B, Cimaz R, Ramazzotti M, Barra G, De Palma R, Maggi E, Liotta F, Cosmi L, Romagnani S, Annunziato F.

Eur J Immunol. 2017 Sep;47(9):1427-1442. doi: 10.1002/eji.201746996. Epub 2017 Jul 6.

PMID:
28612433
7.

Cutaneous leucocytoclastic vasculitis with anti-EJ autoantibodies: mere coincidence or a manifestation of antisynthetase syndrome?

Palterer B, Grandi V, Antiga E, Maio V, Maggi E, Liotta F.

Clin Exp Dermatol. 2017 Apr;42(3):345-347. doi: 10.1111/ced.13063. Epub 2017 Feb 27. No abstract available.

PMID:
28239883
8.

Carry over effects of nutrient addition on the recovery of an invasive seaweed from the winter die-back.

Uyà M, Maggi E, Mori G, Nuccio C, Gribben PE, Bulleri F.

Mar Environ Res. 2017 May;126:37-44. doi: 10.1016/j.marenvres.2017.02.006. Epub 2017 Feb 20.

PMID:
28237887
9.

Preclinical evaluation of radiation and systemic, RGD-targeted, adeno-associated virus phage-TNF gene therapy in a mouse model of spontaneously metastatic melanoma.

Quinn TJ, Healy N, Sara A, Maggi E, Claros CS, Kabarriti R, Scandiuzzi L, Liu L, Gorecka J, Adem A, Basu I, Yuan Z, Guha C.

Cancer Gene Ther. 2017 Jan;24(1):13-19. doi: 10.1038/cgt.2016.70. Epub 2016 Dec 9.

PMID:
27934883
10.

Influence of anti-TNF immunogenicity on safety in rheumatic disease: a narrative review.

Matucci A, Cammelli D, Cantini F, Goletti D, Marino V, Milano GM, Scarpa R, Tocci G, Maggi E, Vultaggio A.

Expert Opin Drug Saf. 2016 Dec;15(sup1):3-10. Review.

PMID:
27924646
11.

Chitinase 3-like-1 is produced by human Th17 cells and correlates with the level of inflammation in juvenile idiopathic arthritis patients.

Capone M, Maggi L, Santarlasci V, Rossi MC, Mazzoni A, Montaini G, Cimaz R, Ramazzotti M, Piccinni MP, Barra G, De Palma R, Liotta F, Maggi E, Romagnani S, Annunziato F, Cosmi L.

Clin Mol Allergy. 2016 Nov 8;14:16. eCollection 2016.

12.

Immunosuppressive Activity of Abatacept on Circulating T Helper Lymphocytes from Juvenile Idiopathic Arthritis Patients.

Maggi L, Cimaz R, Capone M, Santarlasci V, Rossi MC, Mazzoni A, Montaini G, Pagnini I, Giani T, Simonini G, Scaletti C, Liotta F, Maggi E, Annunziato F, Cosmi L.

Int Arch Allergy Immunol. 2016;171(1):45-53. Epub 2016 Nov 8.

13.

Climate-related environmental stress in intertidal grazers: scaling-up biochemical responses to assemblage-level processes.

Maggi E, Cappiello M, Del Corso A, Lenzarini F, Peroni E, Benedetti-Cecchi L.

PeerJ. 2016 Oct 20;4:e2533. eCollection 2016.

14.

An overview on safety of monoclonal antibodies.

Matucci A, Nencini F, Pratesi S, Maggi E, Vultaggio A.

Curr Opin Allergy Clin Immunol. 2016 Dec;16(6):576-581. Review.

PMID:
27749360
15.

Circulating T cells to infliximab are detectable mainly in treated patients developing anti-drug antibodies and hypersensitivity reactions.

Vultaggio A, Petroni G, Pratesi S, Nencini F, Cammelli D, Milla M, Prignano F, Annese V, Romagnani S, Maggi E, Matucci A; ABIRISK Consortium.

Clin Exp Immunol. 2016 Dec;186(3):364-372. doi: 10.1111/cei.12858. Epub 2016 Oct 26.

16.

How the immune system responds to therapeutic biological agents.

Vultaggio A, Petroni G, Pratesi S, Nencini F, Cammelli D, Ferraro A, Maggi E, Matucci A.

J Int Med Res. 2016 Sep;44(1 suppl):38-42.

17.

Technological advances in precision medicine and drug development.

Maggi E, Patterson NE, Montagna C.

Expert Rev Precis Med Drug Dev. 2016;1(3):331-343. Epub 2016 May 5.

18.

Acquisition of an oncogenic fusion protein serves as an initial driving mutation by inducing aneuploidy and overriding proliferative defects.

Loupe JM, Miller PJ, Bonner BP, Maggi EC, Vijayaraghavan J, Zabaleta J, Taylor CM, Tsien F, Crabtree JS, Hollenbach AD.

Oncotarget. 2016 Sep 27;7(39):62814-62835. doi: 10.18632/oncotarget.11716.

19.

Human circulating group 2 innate lymphoid cells can express CD154 and promote IgE production.

Maggi L, Montaini G, Mazzoni A, Rossettini B, Capone M, Rossi MC, Santarlasci V, Liotta F, Rossi O, Gallo O, De Palma R, Maggi E, Cosmi L, Romagnani S, Annunziato F.

J Allergy Clin Immunol. 2017 Mar;139(3):964-976.e4. doi: 10.1016/j.jaci.2016.06.032. Epub 2016 Jul 27.

PMID:
27576126
20.

Retinoblastoma-binding protein 2 (RBP2) is frequently expressed in neuroendocrine tumors and promotes the neoplastic phenotype.

Maggi EC, Trillo-Tinoco J, Struckhoff AP, Vijayaraghavan J, Del Valle L, Crabtree JS.

Oncogenesis. 2016 Aug 22;5(8):e257. doi: 10.1038/oncsis.2016.58.

21.

Dermatophagoides pteronyssinus group 2 allergen bound to 8-OH modified adenine reduces the Th2-mediated airway inflammation without inducing a Th17 response and autoimmunity.

Pratesi S, Nencini F, Filì L, Occhiato EG, Romagnani S, Parronchi P, Maggi E, Vultaggio A.

Mol Immunol. 2016 Sep;77:60-70. doi: 10.1016/j.molimm.2016.07.011. Epub 2016 Jul 29.

PMID:
27475304
22.

Comparative transcriptomic analysis reveals the oncogenic fusion protein PAX3-FOXO1 globally alters mRNA and miRNA to enhance myoblast invasion.

Loupe JM, Miller PJ, Bonner BP, Maggi EC, Vijayaraghavan J, Crabtree JS, Taylor CM, Zabaleta J, Hollenbach AD.

Oncogenesis. 2016 Jul 25;5(7):e246. doi: 10.1038/oncsis.2016.53.

23.

The safety of monoclonal antibodies in asthma.

Passalacqua G, Matucci A, Vultaggio A, Bagnasco D, Mincarini M, Maggi E, Canonica GW.

Expert Opin Drug Saf. 2016 Aug;15(8):1087-95. doi: 10.1080/14740338.2016.1186641. Review.

PMID:
27215447
24.

Th1-Induced CD106 Expression Mediates Leukocytes Adhesion on Synovial Fibroblasts from Juvenile Idiopathic Arthritis Patients.

Maggi L, Margheri F, Luciani C, Capone M, Rossi MC, Chillà A, Santarlasci V, Mazzoni A, Cimaz R, Liotta F, Maggi E, Cosmi L, Del Rosso M, Annunziato F.

PLoS One. 2016 Apr 28;11(4):e0154422. doi: 10.1371/journal.pone.0154422. eCollection 2016.

25.

Loss of MEN1 activates DNMT1 implicating DNA hypermethylation as a driver of MEN1 tumorigenesis.

Yuan Z, Sánchez Claros C, Suzuki M, Maggi EC, Kaner JD, Kinstlinger N, Gorecka J, Quinn TJ, Geha R, Corn A, Pastoriza J, Jing Q, Adem A, Wu H, Alemu G, Du YC, Zheng D, Greally JM, Libutti SK.

Oncotarget. 2016 Mar 15;7(11):12633-50. doi: 10.18632/oncotarget.7279.

26.

Interleukin-17-producing decidual CD4+ T cells are not deleterious for human pregnancy when they also produce interleukin-4.

Lombardelli L, Logiodice F, Aguerre-Girr M, Kullolli O, Haller H, Casart Y, Berrebi A, L'Faqihi-Olive FE, Duplan V, Romagnani S, Maggi E, Rukavina D, Le Bouteiller P, Piccinni MP.

Clin Mol Allergy. 2016 Jan 21;14:1. doi: 10.1186/s12948-016-0039-y. eCollection 2016.

27.

The anti-Müllerian hormone (AMH) acts as a gatekeeper of ovarian steroidogenesis inhibiting the granulosa cell response to both FSH and LH.

Sacchi S, D'Ippolito G, Sena P, Marsella T, Tagliasacchi D, Maggi E, Argento C, Tirelli A, Giulini S, La Marca A.

J Assist Reprod Genet. 2016 Jan;33(1):95-100. doi: 10.1007/s10815-015-0615-y. Epub 2015 Dec 2.

28.

AACR precision medicine series: Highlights of the integrating clinical genomics and cancer therapy meeting.

Maggi E, Montagna C.

Mutat Res. 2015 Dec;782:44-51. doi: 10.1016/j.mrfmmm.2015.10.005. Epub 2015 Nov 3.

PMID:
26554403
29.

Experimental Perturbations Modify the Performance of Early Warning Indicators of Regime Shift.

Benedetti-Cecchi L, Tamburello L, Maggi E, Bulleri F.

Curr Biol. 2015 Jul 20;25(14):1867-72. doi: 10.1016/j.cub.2015.05.035. Epub 2015 Jul 9.

30.

European medicines agency guideline for biological medicinal products: a further step for a safe use of biosimilars.

Agostini C, Canonica GW, Maggi E.

Clin Mol Allergy. 2015 May 15;13(1):3. doi: 10.1186/s12948-015-0010-3. eCollection 2015. No abstract available.

31.

Standardizing terms, definitions and concepts for describing and interpreting unwanted immunogenicity of biopharmaceuticals: recommendations of the Innovative Medicines Initiative ABIRISK consortium.

Rup B, Pallardy M, Sikkema D, Albert T, Allez M, Broet P, Carini C, Creeke P, Davidson J, De Vries N, Finco D, Fogdell-Hahn A, Havrdova E, Hincelin-Mery A, C Holland M, H Jensen PE, Jury EC, Kirby H, Kramer D, Lacroix-Desmazes S, Legrand J, Maggi E, Maillère B, Mariette X, Mauri C, Mikol V, Mulleman D, Oldenburg J, Paintaud G, R Pedersen C, Ruperto N, Seitz R, Spindeldreher S, Deisenhammer F; ABIRISK Consortium.

Clin Exp Immunol. 2015 Sep;181(3):385-400. doi: 10.1111/cei.12652. Epub 2015 Jul 2. Review.

32.

Treatment with 8-OH-modified adenine (TLR7 ligand)-allergen conjugates decreases T helper type 2-oriented murine airway inflammation.

Nencini F, Pratesi S, Petroni G, Filì L, Cardilicchia E, Casini A, Occhiato EG, Calosi L, Bani D, Romagnani S, Maggi E, Parronchi P, Vultaggio A.

Immunology. 2015 Aug;145(4):570-82. doi: 10.1111/imm.12475. Epub 2015 Jun 8.

33.

High serum β-lactams specific/total IgE ratio is associated with immediate reactions to β-lactams antibiotics.

Vultaggio A, Virgili G, Gaeta F, Romano A, Maggi E, Matucci A.

PLoS One. 2015 Apr 16;10(4):e0121857. doi: 10.1371/journal.pone.0121857. eCollection 2015.

34.

Welcome to a new era for Clinical and Molecular Allergy.

Maggi E.

Clin Mol Allergy. 2015 Apr 15;13(1):6. doi: 10.1186/s12948-015-0014-z. eCollection 2015. No abstract available.

35.

Demethylation of the RORC2 and IL17A in human CD4+ T lymphocytes defines Th17 origin of nonclassic Th1 cells.

Mazzoni A, Santarlasci V, Maggi L, Capone M, Rossi MC, Querci V, De Palma R, Chang HD, Thiel A, Cimaz R, Liotta F, Cosmi L, Maggi E, Radbruch A, Romagnani S, Dong J, Annunziato F.

J Immunol. 2015 Apr 1;194(7):3116-26. doi: 10.4049/jimmunol.1401303. Epub 2015 Mar 4.

36.

Mesenchymal stem cells are enriched in head neck squamous cell carcinoma, correlates with tumour size and inhibit T-cell proliferation.

Liotta F, Querci V, Mannelli G, Santarlasci V, Maggi L, Capone M, Rossi MC, Mazzoni A, Cosmi L, Romagnani S, Maggi E, Gallo O, Annunziato F.

Br J Cancer. 2015 Feb 17;112(4):745-54. doi: 10.1038/bjc.2015.15. Epub 2015 Feb 3.

37.

Mechanisms of action of Ig preparations: immunomodulatory and anti-inflammatory effects.

Matucci A, Maggi E, Vultaggio A.

Front Immunol. 2015 Jan 12;5:690. doi: 10.3389/fimmu.2014.00690. eCollection 2014. Review.

38.

Manifestations of Antidrug Antibodies Response: Hypersensitivity and Infusion Reactions.

Vultaggio A, Nencini F, Pratesi S, Petroni G, Maggi E, Matucci A.

J Interferon Cytokine Res. 2014 Dec;34(12):946-952.

PMID:
25493962
39.

Assays and strategies for immunogenicity assessment of biological agents.

Nencini F, Pratesi S, Petroni G, Matucci A, Maggi E, Vultaggio A.

Drug Dev Res. 2014 Nov;75 Suppl 1:S4-6. doi: 10.1002/ddr.21184. Review.

PMID:
25381974
40.

Human Th1 dichotomy: origin, phenotype and biologic activities.

Annunziato F, Cosmi L, Liotta F, Maggi E, Romagnani S.

Immunology. 2014 Oct 5. doi: 10.1111/imm.12399. [Epub ahead of print]

41.

Th17 and non-classic Th1 cells in chronic inflammatory disorders: two sides of the same coin.

Cosmi L, Liotta F, Maggi E, Romagnani S, Annunziato F.

Int Arch Allergy Immunol. 2014;164(3):171-7. doi: 10.1159/000363502. Epub 2014 Jul 12. Review.

PMID:
25033972
42.

Commonness and rarity in the marine biosphere.

Connolly SR, MacNeil MA, Caley MJ, Knowlton N, Cripps E, Hisano M, Thibaut LM, Bhattacharya BD, Benedetti-Cecchi L, Brainard RE, Brandt A, Bulleri F, Ellingsen KE, Kaiser S, Kröncke I, Linse K, Maggi E, O'Hara TD, Plaisance L, Poore GC, Sarkar SK, Satpathy KK, Schückel U, Williams A, Wilson RS.

Proc Natl Acad Sci U S A. 2014 Jun 10;111(23):8524-9. doi: 10.1073/pnas.1406664111. Epub 2014 May 27.

43.

miR-24 regulates menin in the endocrine pancreas.

Vijayaraghavan J, Maggi EC, Crabtree JS.

Am J Physiol Endocrinol Metab. 2014 Jul 1;307(1):E84-92. doi: 10.1152/ajpendo.00542.2013. Epub 2014 May 13.

PMID:
24824656
44.

Cellular and humoral immune responses during tuberculosis infection: useful knowledge in the era of biological agents.

Matucci A, Maggi E, Vultaggio A.

J Rheumatol Suppl. 2014 May;91:17-23. doi: 10.3899/jrheum.140098. Review.

PMID:
24788996
45.

Molecular diagnosis and the Italian Board for ISAC.

Nettis E, Bonifazi F, Bonini S, Di Leo E, Maggi E, Melioli G, Passalacqua G, Senna G, Triggiani M, Vacca A, Canonica GW.

Eur Ann Allergy Clin Immunol. 2014 Mar;46(2):68-73. Review.

PMID:
24739125
46.

Preterm children have unfavorable motor, cognitive, and functional performance when compared to term children of preschool age.

Maggi EF, Magalhães LC, Campos AF, Bouzada MC.

J Pediatr (Rio J). 2014 Jul-Aug;90(4):377-83. doi: 10.1016/j.jped.2013.10.005. Epub 2014 Mar 29.

47.

Brief report: etanercept inhibits the tumor necrosis factor α-driven shift of Th17 lymphocytes toward a nonclassic Th1 phenotype in juvenile idiopathic arthritis.

Maggi L, Cimaz R, Capone M, Santarlasci V, Querci V, Simonini G, Nencini F, Liotta F, Romagnani S, Maggi E, Annunziato F, Cosmi L.

Arthritis Rheumatol. 2014 May;66(5):1372-7. doi: 10.1002/art.38355.

48.

Hapten-specific TH17 cells in the peripheral blood of β-lactam-induced AGEP.

Filì L, Cardilicchia E, Severino MG, Testi S, Matucci A, Vultaggio A, Paglierani M, Massi D, Maggi E, Parronchi P.

Allergol Int. 2014 Mar;63(1):129-31. doi: 10.2332/allergolint.13-LE-0582. Epub 2013 Dec 25. No abstract available.

49.

Perspectives in vaccine adjuvants for allergen-specific immunotherapy.

Filì L, Cardilicchia E, Maggi E, Parronchi P.

Immunol Lett. 2014 Oct;161(2):207-10. doi: 10.1016/j.imlet.2013.12.011. Epub 2013 Dec 19. Review.

PMID:
24361819
50.

IL-4-induced gene 1 maintains high Tob1 expression that contributes to TCR unresponsiveness in human T helper 17 cells.

Santarlasci V, Maggi L, Mazzoni A, Capone M, Querci V, Rossi MC, Beltrame L, Cavalieri D, De Palma R, Liotta F, Cosmi L, Maggi E, Romagnani S, Annunziato F.

Eur J Immunol. 2014 Mar;44(3):654-61. doi: 10.1002/eji.201344047. Epub 2013 Dec 27.

Supplemental Content

Support Center